HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

His-Purkinje system reentry as a proarrhythmic effect of flecainide.

Abstract
We report a case of tachycardia due to reentry within the His-Purkinje system (HPS) occurring after introduction of flecainide. The patient presented with a mild mitral regurgitation and normal left ventricular function. He had incomplete left bundle branch block with left-axis deviation. At the electrophysiology study, a prolonged HV interval was observed at baseline, and the tachycardia could be reproduced after ajmaline infusion. Six months after interruption of flecainide, the patient remains free of arrhythmia recurrence. The authors emphasize that proarrhythmic effects of flecainide may include reentry within the HPS in patients with underlying HPS disease.
AuthorsT Chalvidan, G Cellarier, J C Deharo, R Colin, N Savon, N Barra, J P Peyre, P Djiane
JournalPacing and clinical electrophysiology : PACE (Pacing Clin Electrophysiol) Vol. 23 Issue 4 Pt 1 Pg. 530-3 (Apr 2000) ISSN: 0147-8389 [Print] United States
PMID10793448 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Ajmaline
  • Flecainide
Topics
  • Administration, Oral
  • Aged
  • Ajmaline (administration & dosage)
  • Anti-Arrhythmia Agents (administration & dosage, adverse effects)
  • Bundle of His (drug effects, physiopathology)
  • Bundle-Branch Block (chemically induced, drug therapy, physiopathology)
  • Electrocardiography (drug effects)
  • Female
  • Flecainide (administration & dosage, adverse effects)
  • Humans
  • Infusions, Intravenous
  • Purkinje Fibers (drug effects, physiopathology)
  • Tachycardia, Ventricular (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: